Homechevron_rightAll Peptideschevron_rightGLOW Blend Injection Pen

verified_user

Safety data sheet

Standardized safety protocols and material specifications for professional use.

analytics

Certificate of Analysis

Purity verified via High-Performance Liquid Chromatography (HPLC) for #myo-glow-peptide-blend-injection-pen-70mg

Official Product Data Sheet

GLOW Blend Injection Pen (70mg)

High >98% Purity

Vial Contents

70 mg GLOW blend (BPC-157 + TB-500 + GHK-Cu) — 3 mL pre-filled injection pen

Includes

Ready-to-use multi-dose injection pen — no mixing or reconstitution required

Form

Pre-filled multi-dose peptide blend pen

Purity

≥98%, third-party verified

Sequence

BPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val | TB-500: Acetyl-LKKTETQ | GHK-Cu: Glycyl-L-histidyl-L-lysine copper complex

Molecular Formula

See chemical properties

Molecular Mass

N/A

CAS No.

BPC-157: 137525-51-0 | TB-500: 77591-33-4 | GHK-Cu: 300801-03-0

Solubility

Concentration: ≈23.33 mg/mL total | Per click: 1 unit ≈ 233 mcg (0.233 mg)

Storage

Refrigerate at 2–8 °C. Protect from light. Do not freeze.

Authorized Resellers

Available through our trusted partners

verifiedVerified

123peptide.com

Netherlands · Europe

local_shipping2-3 Business Days

Buy from Partneropen_in_new

verifiedVerified

Depeptidenwinkel.com

Netherlands · Europe

local_shipping2-3 Business Days

Buy from Partneropen_in_new

View all authorized resellersshopping_cart

swipe_rightSwipe to see all tabs

Scientific Background

GLOW is a research-focused peptide blend combining BPC-157, TB-500, and GHK-Cu in a pre-filled injection pen for comprehensive tissue healing, inflammation control, and skin rejuvenation. BPC-157 promotes localized repair and VEGF-mediated angiogenesis, TB-500 enhances cell migration and new blood vessel formation, while GHK-Cu stimulates collagen production, fights oxidative stress, and rejuvenates skin at a cellular level. Together these three peptides target multiple healing pathways for synergistic regenerative effects.

Intended Research Use

Multi-pathway tissue repair and regeneration research
Angiogenesis and cell migration studies (BPC-157 + TB-500)
Collagen synthesis and extracellular matrix remodeling research
Anti-inflammatory and wound healing investigations
Skin rejuvenation and antioxidant protection studies (GHK-Cu)

menu_bookScientific Publications

article

Int J Mol Sci (2018)

Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data

open_in_newhttps://pubmed.ncbi.nlm.nih.gov/29986520/

article

Pharmaceuticals (Basel) (2025)

Multifunctionality and Possible Medical Application of BPC-157: Literature and Patent Review

open_in_newhttps://pubmed.ncbi.nlm.nih.gov/38156225/

article

J Appl Physiol (2011)

The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration

open_in_newhttps://pubmed.ncbi.nlm.nih.gov/21030672/

article

Expert Opin Biol Ther (2012)

Thymosin β4: A Multi-Functional Regenerative Peptide

open_in_newhttps://pubmed.ncbi.nlm.nih.gov/22074294/

warning

FOR RESEARCH USE ONLY. This product is intended for laboratory research purposes only and is not for human consumption, medical, or diagnostic use.

Possible stacks with other peptides

Synergistic combinations for enhanced research outcomes

GLOW's triple-peptide blend pairs well with targeted standalone peptides for intensified research into specific healing pathways.

GHK-Cu 50mg (50mg vial)

arrow_forward

myo-ghk-cu-50mg

Intensified skin rejuvenation and collagen support — additional GHK-Cu alongside the GLOW blend for deeper cellular repair and antioxidant research.

BPC-157 10mg (10mg vial)

arrow_forward

myo-bpc-157-10mg

Deeper localized tissue repair synergy — additional BPC-157 for targeted injury-site administration alongside the systemic GLOW blend.

TB-500 5mg (5mg vial)

arrow_forward

myo-tb-500-5mg

Amplified angiogenesis and systemic recovery — additional TB-500 for extended cell migration and blood vessel formation research alongside the GLOW blend.

schedule

Cycling Note: Typical protocol: 4–8 weeks continuous at 10 units/day. One pen lasts approximately 30 days.

Also Available

Vial

GLOW Blend

70mg